Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic …
OBJECTIVES: To review systematically the clinical effectiveness and the cost-effectiveness
of clopidogrel used in combination with standard therapy including aspirin, compared with …
of clopidogrel used in combination with standard therapy including aspirin, compared with …
Platelets, arterial thrombosis and cerebral ischemia
L Badimon, G Vilahur - Cerebrovascular Diseases, 2007 - karger.com
Atherosclerosis is a systemic disease that starts early in life, asymptomatically progressing
though adulthood, until clinically manifested. In the last few years, experimental, clinical and …
though adulthood, until clinically manifested. In the last few years, experimental, clinical and …
Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases
ZG Li, ZC Yu, DZ Wang, WP Ju, X Zhan… - Neurological …, 2008 - Taylor & Francis
Background and purpose: Lysophosphatidic acid (LPA) is released from activated platelets.
Acetylsalicylate (aspirin) is the most commonly used antiplatelet drug. The purpose of this …
Acetylsalicylate (aspirin) is the most commonly used antiplatelet drug. The purpose of this …
Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats
JH Lee, SY Park, WS Lee, KW Hong - Neurological research, 2005 - Taylor & Francis
Objectives: This study evaluated the antiapoptotic effect of antiplatelet drugs, aspirin and
clopidogrel, and the antioxidant drug, MCI-186, against focal cerebral ischemic rat brain …
clopidogrel, and the antioxidant drug, MCI-186, against focal cerebral ischemic rat brain …
Cost‐Effectiveness of Antiplatelet Agents in Secondary Stroke Prevention: The Limits of Certainty
DB Matchar, GP Samsa, S Liu - Value in health, 2005 - Wiley Online Library
Which of the available antiplatelet therapies should be preferred for secondary prevention of
recurrent ischemic stroke has been contentious. Objective: We applied the Duke Stroke …
recurrent ischemic stroke has been contentious. Objective: We applied the Duke Stroke …
阿司匹林对缺血性脑血管病患者血浆溶血磷脂酸含量的影响(英文)
李振光， 伍期专， 于占彩， 姚存姗， 唐朝枢… - 国外医学(脑血管疾病 …, 2005 - cqvip.com
目的: 观察缺血性脑血管病患者应用阿司匹林后能否降低血浆溶血磷脂酸(LPA) 含量. 方法: 1400
例患者纳入本研究, 其中803 例诊为可能的缺血性脑血管病, 343 例为缺血性脑血管病. 36 …
例患者纳入本研究, 其中803 例诊为可能的缺血性脑血管病, 343 例为缺血性脑血管病. 36 …
Secondary prevention of stroke: a practical guide to drug treatment
HC Koennecke - CNS drugs, 2004 - Springer
Stroke is a disease of the elderly and, as a result of the expected demographic changes in
many industrialised countries, its incidence is likely to increase in the future. A first-ever …
many industrialised countries, its incidence is likely to increase in the future. A first-ever …
抗血小板药物联合治疗在缺血性脑血管病中的应用
甘后军 - 安徽医药, 2006 - cqvip.com
抗血小板药物具有不同的作用机制, 用于治疗频发性动脉疾病, 包括脑血管疾病.
近期的脑血管及心血管试验表明, 联合治疗可以有效的预防缺血性脑血管病 …
近期的脑血管及心血管试验表明, 联合治疗可以有效的预防缺血性脑血管病 …
Platelets and new antiplatelet drugs
RA Reiter, B Jilma - Clinical Practice, 2005 - search.proquest.com
Platelets play an important, life-saving role in hemostasis and blood clotting at sites of
vascular injury. However, unwanted platelet activation and arterial thrombus formation are …
vascular injury. However, unwanted platelet activation and arterial thrombus formation are …
Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist
M Fisher - Archives of neurology, 2006 - jamanetwork.com
The secondary prevention of ischemic stroke is aided by the use of antiplatelet therapy, and
the predominant current choices are aspirin, aspirin plus extended-release dipyridamole …
the predominant current choices are aspirin, aspirin plus extended-release dipyridamole …